Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
3(27%)
Results Posted
0%(0 trials)
Terminated
1(9%)

Phase Distribution

Ph phase_2
2
18%
Ph phase_1
2
18%
Ph phase_3
1
9%
Ph not_applicable
3
27%

Phase Distribution

2

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
2(25.0%)
Phase 2Efficacy & side effects
2(25.0%)
Phase 3Large-scale testing
1(12.5%)
N/ANon-phased studies
3(37.5%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

3

trials recruiting

Total Trials

11

all time

Status Distribution
Active(3)
Completed(4)
Terminated(1)
Other(3)

Detailed Status

Completed4
unknown3
Recruiting3
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
3
Success Rate
80.0%
Most Advanced
Phase 3

Trials by Phase

Phase 12 (25.0%)
Phase 22 (25.0%)
Phase 31 (12.5%)
N/A3 (37.5%)

Trials by Status

unknown327%
completed436%
terminated19%
recruiting327%

Recent Activity

3 active trials
Showing 5 of 11
recruitingphase_2

Clinical Study of HiR+X Therapy for Newly Diagnosed Elderly Patients with DLBCL Intolerant to Chemotherapy

NCT06758037
recruiting

Revascularization Effect on CSVD Burden in Carotid Artery Stenosis

NCT06031610
recruitingphase_1

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Safety and Efficacy of Uterine Blood Mesenchymal Stem Cells Injection for the Treatment of Severe Pneumonia Caused by Viruses

NCT06693362
completednot_applicable

Rehabilitative Therapy and Pridinol in Patients With Lumbar Spondylarthrosis and Chronic Low Back Pain

NCT06252064
unknown

Early Diagnosis and Timely Treatment of Cirrhotic Patients With Minimal Hepatic Encephalopathy (CHESS-NCRCID 2106)

NCT05140837
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT06758037Phase 2

Clinical Study of HiR+X Therapy for Newly Diagnosed Elderly Patients with DLBCL Intolerant to Chemotherapy

Recruiting
NCT06031610

Revascularization Effect on CSVD Burden in Carotid Artery Stenosis

Recruiting
NCT06693362Phase 1

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Safety and Efficacy of Uterine Blood Mesenchymal Stem Cells Injection for the Treatment of Severe Pneumonia Caused by Viruses

Recruiting
NCT06252064Not Applicable

Rehabilitative Therapy and Pridinol in Patients With Lumbar Spondylarthrosis and Chronic Low Back Pain

Completed
NCT05140837

Early Diagnosis and Timely Treatment of Cirrhotic Patients With Minimal Hepatic Encephalopathy (CHESS-NCRCID 2106)

Unknown
NCT03122002

Predictors and Prognostic Factors on the Acute Ischemic Stroke

Terminated
NCT05047159Not Applicable

The Role of Neuromodulation Technique In Depression Disorder

Unknown
NCT02869971Phase 3

Prostatic Artery Embolization Versus Medical Treatment in Symptomatic Benign Prostatic Hyperplasia

Completed
NCT04635956Phase 2

Camrelizumab Combined With Chemotherapy for Recurrent or Advanced Cervical Neuroendocrine Carcinomas

Unknown
NCT00050050Phase 1

Cognitive Behavioral Therapy for Adult Attention Deficit Hyperactivity Disorder

Completed
NCT00158301Not Applicable

Cognitive Behavioral Therapy for Depression Relapse Prevention in Children and Adolescents

Completed

All 11 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
11